Report

src

Global Women's Health Market by Product Type (EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL and ORTHO TRI-CY LO (28).) and by End-Users/Application (Hormonal infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic ovary syndrome, and Other applications) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2020 - 2027

 Report Code
 Category
 Published Date
 Pages
 Format
MNR-1350
Healthcare
03 June 2020
220
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

The report on the global women´s health market analyzes complete scenario i.e., existing as well as future visions of recovered women´s health market. It includes detailed overview of women´s health market along with market pictures. Additionally, report has included complete data of the various segments in the global women´s health market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global Women´s health market report offers in-depth insights, revenue details, and other vital information regarding the global women´s health market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of women´s health market.

Market Segmentation:
Segmentation by Type EVISTA 
XGEVA 
Prolia
Mirena
Zometa
Reclast/Aclasta
Minastrin 24 Fe
NuvaRing
FORTEO
Premarin
ACTONEL
ORTHO TRI-CY LO (28)
Segmentation by Application Hormonal Infertility 
Postmenopausal Osteoporosis
Endometriosis
Contraceptives
Menopause
Polycystic Ovary Syndrome
Other Applications
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, women´s health market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global women´s health market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Women´s Health Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each women´s health market player.
  • Region-wise and country-wise breakdown of the women´s health market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global women´s health market.
  • Year-on-year growth of the global recovered women´s health market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish recovered women´s health market and nurture business as it explains current global market as well as future market.
 

Chapter 1 Women´s Health Market Overview
1.1 Product Overview and Scope of Women´s Health Market

Chapter 2 Executive Summary 
2.1 Drivers for Women´s Health Market:
2.2 Restrain for Women´s Health Market:
2.3 Opportunity for Women´s Health  Market:
2.4 Global Women´s Health  Market, 2015 - 2027
2.5 Global Women´s Health  Market, by Region, 2015 - 2027
2.6 Global Women´s Health  Market, by Type, 2015 - 2027
2.7 Global Women´s Health  Market, by Application, 2015 - 2027

Chapter 3 Women´s Health Segment by Types (Product Category) 
3.1 Global Women´s Health Revenue (USD Billion) and Growth Rate (%) Comparison by Types (2015-2020)
3.2 Global Women´s Health  Revenue Market Share (%) by Types in 2019
3.3 EVISTA
3.4 XGEVA
3.5 Prolia
3.6 Mirena
3.7 Zometa
3.8 Reclast/Aclasta
3.9 Minastrin 24 Fe
3.10 NuvaRing
3.11 FORTEO
3.12 Premarin
3.13 ACTONEL
3.14 ORTHO TRI-CY LO (28)

Chapter 4 Global Women´s Health Segment by Application 
4.1 Global Women´s Health  Revenue (USD Billion) Comparison by Application (2015-2027)
4.2 Hormonal Infertility
4.3 Postmenopausal Osteoporosis
4.4 Endometriosis
4.5 Contraceptives
4.6 Menopause
4.7 Polycystic Ovary Syndrome
4.8 Other Applications
 
Chapter 5 Global Women´s Health Market by Regions (2015-2027) 
5.1 Global Women´s Health  Market Size and Growth Rate (%) Comparison by Regions (2015-2027)
5.2 North America Women´s Health  Status and Prospect (2015-2027)
5.3 Europe Women´s Health Status and Prospect (2015-2027) 
5.4 Asia Pacific Women´s Health  Status and Prospect (2015-2027) 
5.5 South America Women´s Health  Status and Prospect (2015-2027)
5.6 Middle East & Africa Women´s Health  Status and Prospect (2015-2027)
5.7 Global Women´s Health  Market Size (2015-2027)
            5.7.1 Global Women´s Health Revenue Status and Outlook (2015-2027)
            
Chapter 6 Global Women´s Health Market Competition by Manufacturers
6.1 Global Women´s Health Revenue and Share by Manufacturers (2015-2019)

Chapter 7 Company (Top Players) Profiles and Key Data
7.1 Bayer AG
            7.1.1 Company basic information and sales area
            7.1.2 Business Segment/ Overview
            7.1.3 Investment in Research and Development
            7.1.4 Women´s Health  Product Types Specification
            7.1.5 Key Developments
            7.1.6 Business Strategy
7.2 Allergan
            7.2.1 Company basic information and sales area 
            7.2.2 Business Segment/ Overview
            7.2.3 Investment in Research and Development
            7.2.4 Women´s Health Product Types Specification
            7.2.5 Business Strategy
7.3 Merck & Co.
            7.3.1 Company basic information and sales area 
            7.3.2 Business Segment/ Overview
            7.3.3 Women´s Health  Product Types Specification
            7.3.4 Key Developments
            7.3.5 Business Strategy
7.4 Pfizer Inc.
            7.4.1 Company basic information and sales area 
            7.4.2 Business Segment/ Overview
            7.4.3 Women´s Health Product Types Specification
            7.4.4 Business Strategy
7.5 Amgen
            7.5.1 Company basic information and sales area 
            7.5.2 Business Segment/ Overview
            7.5.3 Women´s Health Product Types Specification
            7.5.4 Business Strategy
7.6 Agile Therapeutics Inc.
            7.6.1 Company basic information and sales area 
            7.6.2 Business Segment/ Overview
            7.6.3 Women´s Health Product Types Specification
            7.6.4 Business Strategy
7.7  Ferring Pharmaceuticals
            7.7.1 Company basic information and sales area 
            7.7.2 Business Segment/ Overview
            7.7.3 Investment in Research and Development
            7.7.4 Women´s Health Product Types Specification
            7.7.5 Key Developments
            7.7.6 Business Strategy
7.8  Mylan N.V.
            7.8.1 Company basic information and sales area 
            7.8.2 Business Segment/ Overview
            7.8.3 Women´s Health Product Types Specification
            7.8.4 Business Strategy
7.9 Lupin
            7.9.1 Company basic information and sales area 
            7.9.2 Business Segment/ Overview
            7.9.3 Women´s Health Product Types Specification
            7.9.4 Business Strategy
7.10 Blairex Laboratories
            7.10.1  Company basic information and sales area 
            7.10.2 Business Segment/ Overview
            7.10.3 Women´s Health  Product Types Specification
            7.10.4 Business Strategy
            
Chapter 8 Global Women´s Health Revenue by Regions (2015-2020)
8.1 Global Women´s Health  Revenue and Market Share (%) by Regions (2015-2020)

Chapter 9 Global Women´s Health Revenue by Types
9.1 Global Women´s Health  Revenue and Market Share (%) by Types (2015-2020)

Chapter 10 Global Women´s Health Market Analysis by Application
10.1 Global Women´s Health  Revenue (USD Billion) and Market Share (%) by Application (2015-2020)
10.2 Global Women´s Health  Revenue Growth Rate by Application (2015-2020)

Chapter 11 North America Women´s Health Market Development Status and Outlook
11.1 North America Women´s Health Market Size (2015-2020)
            11.1.1 North America Women´s Health  Market Size by Type (USD Billion) (2015-2020)
11.2 North America Women´s Health Market Size (2015-2020)
            11.2.1 North America Women´s Health  Market Size by Application (USD Billion) (2015-2020)
11.3 U.S
            11.3.1 U.S. Women´s Health  Market, by Type, 2015 - 2027
            11.3.2 U.S. Women´s Health Market, by Application, 2015 – 2027
11.4 Canada
            11.4.1 Canada Women´s Health Market, by Type, 2015 - 2027
            11.4.2 Canada Women´s Health Market, by Application, 2015 – 2027
11.5 Mexico
            11.5.1 Mexico Women´s Health  Market, by Type, 2015 - 2027
            11.5.2 Mexico Women´s Health Market, by Application, 2015 – 2027
            
Chapter 12 Europe Women´s Health Market Development Status and Outlook
12.1 Europe Women´s Health  Market Size (2015-2020)
            12.1.1 Europe Women´s Health Market Size by Type (USD Billion) (2015-2020)
12.2 Europe Women´s Health Market Size (2015-2020)
            12.2.1 Europe Women´s Health  Market Size by Application (USD Billion) (2015-2020)
12.3 U.K.
            12.3.1 U.K. Women´s Health  Market, by Type, 2015 - 2027
            12.3.2 U.K. Women´s Health  Market, by Application, 2015 – 2027
12.4 Germany
            12.4.1 Germany Women´s Health Market, by Type, 2015 - 2027
            12.4.2 Germany Women´s Health  Market, by Application, 2015 – 2027
12.5 France
            12.5.1 France Women´s Health  Market, by Type, 2015 – 2027
            12.5.2 France Women´s Health Market, by Application, 2015 – 2027
12.6 Italy
            12.6.1 Italy Women´s Health  Market, by Type, 2015 – 2027
            12.6.2 Italy Women´s Health Market, by Application, 2015 – 2027
12.7 Spain
            12.7.1 Spain Women´s Health  Market, by Type, 2015 – 2027
            12.7.2 Spain Women´s Health Market, by Application, 2015 – 2027
12.8  Rest of Europe
            12.8.1 Rest of Europe Women´s Health  Market, by Type, 2015 – 2027
            12.8.2 Rest of Europe Women´s Health Market, by Application, 2015 – 2027
            
Chapter 13 Asia Pacific Women´s Health Market Development Status and Outlook
13.1 Asia Pacific Women´s Health  Market Size (2015-2020)
            13.1.1 Asia Pacific Women´s Health  Market Size by Type (USD Billion) (2015-2020)
13.2 Asia Pacific Women´s Health  Market Size (2015-2020)
            13.2.1 Asia Pacific Women´s Health  Market Size by Application (USD Billion) (2015-2020)
13.3 China
            13.3.1 China Women´s Health Market, by Type, 2015 – 2027
            13.3.2 China Women´s Health Market, by Application, 2015 – 2027
13.4 Japan
            13.4.1 Japan Women´s Health Market, by Type, 2015 – 2027
            13.4.2 Japan Women´s Health Market, by Application, 2015 – 2027
13.5 India
            13.5.1 India Women´s Health Market, by Type, 2015 – 2027
            13.5.2 India Women´s Health Market, by Application, 2015 – 2027
13.6  Southeast Asia
            13.6.1 Southeast Asia Women´s Health Market, by Type, 2015 – 2027
            13.6.2 Southeast Asia Women´s Health Market, by Application, 2015 – 2027
            
Chapter 14 South America Women´s Health Market Development Status and Outlook
14.1 South America Women´s Health Market Size (2015-2020)
            14.1.1 South America Women´s Health  Market Size by Type (USD Billion) (2015-2020) 
14.2 South America Women´s Health  Market Size (2015-2020)
            14.2.1 South America Women´s Health Market Size by Application (USD Billion) (2015-2020)
14.3 Brazil
            14.3.1 Brazil Women´s Health  Market, by Type, 2015 – 2027
            14.3.2 Brazil Women´s Health  Market, by Application, 2015 – 2027
14.4 Argentina
            14.4.1 Argentina Women´s Health Market, by Type, 2015 – 2027
            14.4.2 Argentina Women´s Health  Market, by Application, 2015 – 2027 
14.5 Colombia
            14.5.1 Colombia Women´s Health  Market, by Type, 2015 – 2027
            14.5.2 Colombia Women´s Health  Market, by Application, 2015 – 2027
14.6 Rest of South America
            14.6.1 Colombia Women´s Health  Market, by Type, 2015 – 2027
            14.6.2 Colombia Women´s Health Market, by Application, 2015 – 2027
            
Chapter 15 Middle East & Africa Women´s Health Market Development Status and Outlook
15.1 Middle East & Africa Women´s Health Market Size (2015-2020)
            15.1.1 Middle East & Africa Women´s Health Market Size by Type (USD Billion) (2015-2020)
15.2 Middle East & Africa Women´s Health  Market Size (2015-2020)
            15.2.1 Middle East & Africa Women´s Health  Market Size by Application (2015-2020)
15.3 UAE
            15.3.1 UAE Women´s Health  Market, by Type, 2015 – 2027
            15.3.2 UAE Women´s Health Market, by Application, 2015 – 2027
15.4 South Africa
            15.4.1 South Africa Women´s Health  Market, by Type, 2015 – 2027
            15.4.2 South Africa Women´s Health Market, by Application, 2015 – 2027
15.5 Egypt
            15.5.1 Egypt Women´s Health Market, by Type, 2015 – 2027
            15.5.2 Egypt Women´s Health Market, by Application, 2015 – 2027
15.6 Rest of MEA
            15.6.1 Rest of MEA Women´s Health Market, by Type, 2015 – 2027
            15.6.2 Rest of MEA Women´s Health Market, by Application, 2015 – 2027
            
Chapter 16 Women´s Health Manufacturing Cost Analysis
16.1 Proportion of Manufacturing Cost Structure
            16.1.1 Raw Materials
            16.1.2 Labor Cost
            16.1.3 USA Labor Cost Analysis
            16.1.4 EU Labor Costs Analysis
            16.1.5 China Labor Costs Analysis
            16.1.6 Manufacturing Expenses
            
Chapter 17 Marketing Strategy Analysis, Distributors/Traders
17.1 Marketing Channel
            17.1.1 Direct Marketing
            17.1.2 Indirect Marketing
            17.1.3 Marketing Channel Development Trend
17.2 Market Positioning
            17.2.1 Pricing Strategy
            
Chapter 18 Women´s Health Market Forecast (2020-2027)
18.1 Global Women´s Health Revenue Forecast (2020-2027)
            18.1.1 Global Women´s Health Revenue (USD Billion) and Growth Rate (%) Forecast (2020-2027)
18.2 Global Women´s Health Revenue (USD Billion) Forecast by Regions (2020-2027)
            18.2.1 North America Women´s Health  Revenue (USD Billion) Forecast (2020-2027)
            18.2.2 Europe Women´s Health  Revenue (USD Billion) Forecast (2020-2027)
            18.2.3 Asia Pacific Women´s Health  and Revenue (USD Billion) Forecast (2020-2027)
            18.2.4 South America Women´s Health  and Revenue (USD Billion) Forecast (2020-2027)
            18.2.5 Middle East & Africa Women´s Health  and Revenue (USD Billion) Forecast (2020-2027)
18.3 Global Women´s Health  Revenue Forecast by Type (2020-2027)
18.4 Global Women´s Health  Revenue (USD Billion) Forecast by Application (2020-2027)

Chapter 19 North America Women´s Health Market Development Status and Outlook
19.1 North America Women´s Health  Market Size (2020-2027)
            19.1.1 North America Women´s Health  Market Size by Type (USD Billion) (2020-2027)
19.2 North America Women´s Health Market Size (2020-2027)
            19.2.1 North America Women´s Health Market Size by Application (USD Billion) (2020-2027)
19.3 U.S.
            19.3.1 U.S. Women´s Health  Market, by Type, 2020 – 2027
            19.3.2 U.S. Women´s Health Market, by Application, 2020 – 2027
19.4 Canada
            19.4.1 Canada Women´s Health  Market, by Type, 2020 – 2027
            19.4.2 Canada Women´s Health Market, by Application, 2020 – 2027
19.5 Mexico
            19.5.1 Mexico Women´s Health Market, by Type, 2020 – 2027
            19.5.2 Mexico Women´s Health Market, by Application, 2020 – 2027
            
Chapter 20 Europe Women´s Health Market Development Status and Outlook
20.1 Europe Women´s Health  Market Size (2020-2027)
            20.1.1 Europe Women´s Health Market Size by Type (USD Billion) (2020-2027)
20.2 Europe Women´s Health Market Size (2020-2027)
            20.2.1 Europe Women´s Health Market Size by Application (USD Billion) (2020-2027)
20.3 U.K.
            20.3.1 U.K. Women´s Health  Market, by Type, 2020 – 2027
            20.3.2 U.K. Women´s Health Market, by Application, 2020 – 2027
20.4 Germany
            20.4.1 Germany Women´s Health  Market, by Type, 2020 – 2027
            20.4.2 Germany Women´s Health Market, by Application, 2020 – 2027
20.5 France
            20.5.1 France Women´s Health Market, by Type, 2020 – 2027
            20.5.2 France Women´s Health Market, by Application, 2020 – 2027
20.6 Italy
            20.6.1 France Women´s Health Market, by Type, 2020 – 2027
            20.6.2 France Women´s Health Market, by Application, 2020 – 2027
20.7 Spain
            20.7.1 France Women´s Health Market, by Type, 2020 – 2027
            20.7.2 France Women´s Health Market, by Application, 2020 – 2027
20.8 Rest of Europe
            20.8.1 France Women´s Health Market, by Type, 2020 – 2027
            20.8.2 France Women´s Health Market, by Application, 2020 – 2027
            
Chapter 21 Asia Pacific Women´s Health Market Development Status and Outlook
21.1 Asia PacificWomen´s Health  Market Size (2020-2027)
            21.1.1 Asia Pacific Women´s Health Market Size by Type (USD Billion) (2020-2027)
21.2 Asia PacificWomen´s Health Market Size (2020-2027)
            21.2.1 Asia Pacific Women´s Health Market Size by Application (USD Billion) (2020-2027)
21.3 China
            21.3.1 China Women´s Health  Market, by Type, 2020 – 2027
            21.3.2 China Women´s Health  Market, by Application, 2020 – 2027
21.4 Japan
            21.4.1 Japan Women´s Health Market, by Type, 2020 – 2027
            21.4.2 Japan Women´s Health Market, by Application, 2020 – 2027
21.5 India
            21.5.1 India Women´s Health Market, by Type, 2020 – 2027
            21.5.2 India Women´s Health Market, by Application, 2020 – 2027
21.6 Southeast Asia
            21.6.1 Southeast Asia Women´s Health Market, by Type, 2020 – 2027
            21.6.2 Southeast Asia Women´s Health Market, by Application, 2020 – 2027
            
Chapter 22 South America Women´s Health Market Development Status and Outlook
22.1 South America Women´s Health Market Size (2020-2027)
            22.1.1 South America Women´s Health Market Size by Type (USD Billion) (2020-2027)
22.2 South America Women´s Health Market Size (2020-2027)
            22.2.1 South America Women´s Health Market Size by Application (USD Billion) (2020-2027)
22.3 Brazil
            22.3.1 Brazil Women´s Health Market, by Type, 2020 – 2027
            22.3.2 Brazil Women´s Health Market, by Application, 2020 – 2027 
22.4 Argentina
            22.4.1 Argentina Women´s Health Market, by Type, 2020 – 2027
            22.4.2 Argentina Women´s Health Market, by Application, 2020 – 2027 
22.5 Colombia
            22.5.1 Colombia Women´s Health Market, by Type, 2020 – 2027
            22.5.2 Colombia Women´s Health Market, by Application, 2020 – 2027
22.6 Rest of South America
            22.6.1 Colombia Women´s Health Market, by Type, 2020 – 2027
            22.6.2 Colombia Women´s Health Market, by Application, 2020 – 2027
            
Chapter 23 Middle East & Africa Women´s Health Market Development Status and Outlook
23.1 Middle East & Africa Women´s Health Market Size (2020-2027)
            23.1.1 Middle East & Africa Women´s Health Market Size by Type (USD Billion) (2020-2027)
23.2 Middle East & Africa Women´s Health Market Size (2020-2027)
            23.2.1 Middle East & Africa Women´s Health Market Size by Application (USD Billion) (2020-2027)
23.3 UAE
            23.3.1 UAE Women´s Health  Market, by Type, 2020 – 2027
            23.3.2 UAE Women´s Health Market, by Application, 2020 – 2027
23.4 South Africa
            23.4.1 South Africa Women´s Health  Market, by Type, 2020 – 2027
            23.4.2 South Africa Women´s Health Market, by Application, 2020 – 2027
23.5 Egypt
            23.5.1 Egypt Women´s Health Market, by Type, 2020 – 2027
            23.5.2 Egypt Women´s Health  Market, by Application, 2020 – 2027
24.6 Rest of MEA
            24.6.1 Rest of MEA Women´s Health Market, by Type, 2020 – 2027
            24.6.2 Rest of MEA Women´s Health  Market, by Application, 2020 – 2027
            
Chapter 25 Research Findings and Conclusion
 

No Methodology

Global Women´s Health Market Trends:
The global women´s health market is estimated to be worth USD 9.6 billion in 2019 and is projected to reach USD 55.7 billion by 2027, at a CAGR of 13.2 % from 2020 to 2027.

Women´s health refers to the health problems that are specific to women. It is associated with certain unique issues - menopause, pregnancy and conditions of the female organs. It also includes medical situations in which women face problems directly or indirectly related to their biology and due lack of access to medical treatment.

Increased awareness campaigns by the government are some of the major attributes which drives the growth of the market. Moreover, increased research and developments are also some of the major factors which boost the growth of the market. However, limited awareness and less income levels in several developing countries are some of the major challenges which hinder the growth of the market.

Global Women´s Health Market, By Type:
Based on the types, it can be segmented into EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL and ORTHO TRI-CY LO (28). On the basis of type, EVISTA accounted for the largest share in the estimated forecast period. Some of the factors such as increased demand for the drugs for the osteoporosis and increased prevalence and occurrence of hormonal changes are likely to have an impact on the growth of the market.

Global Women´s Health Market, By Application:
Based on applications, it can be segmented into hormonal infertility, postmenopausal osteoporosis, endometriosis, contraceptives, menopause, polycystic ovary syndrome, and other applications. Based on its application, hormonal infertility accounted for the largest share in the estimated forecasts period. This can be attributed to the increasing demand for hormonal therapy drugs, and due to the high prevalence of postmenopausal osteoporosis among women. These are some of the major factor responsible for the growth of this market segment.

Global Women´s Health   Market, By Region:
Report covers the region wise analysis; global women´s health market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, North America has the largest segment, which can be attributed to the increasing median age of first-time pregnancies, and increased healthcare spending in the US and Canada. Moreover, the increased awareness and understanding regarding contraceptives among American women and the easy access to modern contraception as compared to developing countries propel the market growth in this region.

Major Market Players:
Some of the major players in the market are Bayer AG, Allergan, Merck & Co., Pfizer Inc., Amgen, Agile Therapeutics Inc., Ferring Pharmaceuticals, Mylan N.V., Lupin, and Blairex Laboratories. In October 2018, Mylan launched Medroxyprogesterone Acetate Injectable Suspension – generic drug for birth control.

Global Women´s Health Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Billion)
Covered Segments Product Type, Applications, Geographic Regions
Product Type EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL and ORTHO TRI-CY LO (28)
Applications Hormonal infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic ovary syndrome, and Other applications
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Bayer AG, Allergan, Merck & Co., Pfizer Inc., Amgen, Agile Therapeutics Inc., Ferring Pharmaceuticals, Mylan N.V., Lupin, and Blairex Laboratories

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global women´s health market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Women´s Health Market: Product analysis
  • EVISTA
  • XGEVA
  • Prolia
  • Mirena
  • Zometa
  • Reclast/Aclasta
  • Minastrin 24 Fe
  • NuvaRing
  • FORTEO
  • Premarin
  • ACTONEL
  • ORTHO TRI-CY LO (28)
Global Women´s Health Market: Application analysis
  • Hormonal Infertility
  • Postmenopausal Osteoporosis
  • Endometriosis
  • Contraceptives
  • Menopause
  • Polycystic Ovary Syndrome
  • Other Applications
Market, By Regions:
In addition, women´s health market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)
 
 
 

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase